November 21, 2009 – The Food and Drug Administration (FDA) recently announced that it is reviewing data from a study suggesting patients using the drug sibutramine may have a higher number of cardiovascular events than patients using a placebo.
November 29, 2009 - A new advanced visualization and decision support software upgrade is designed to improve management of CT stroke protocols and 3D or 2D viewing. It also provides electronic medical record (EMR) integration.
November 24, 2009 - Seventy million dollars in grant money will go to community college training programs for health information technology professionals, and $10 million is designated to develop educational materials to support these programs.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
November 24, 2009 – European CE mark clearance was granted this week for BridgePoint Medical’s coronary and peripheral chronic total occlusion (CTO) crossing system comprised of the CrossBoss CTO Crossing Catheter and the Stingray CTO Re-Entry System.
November 24, 2009 - The academic and research communities can access free 2D/3D Windows-based software for reviewing imaging data from CT, MR, PET, ultrasound and X-ray.
November 24, 2009 – New imaging client-server technology is designed to create efficiency and ease of use from any location. With an unlimited number of installed clients, there can be 3/10/20 concurrent users, depending on server hardware configuration and system load.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
November 23, 2009 – Using less lytic drug and offering faster clot dissolution than traditional deep vein thrombosis (DVT) treatments, EKOS Corp. launched the EkoSonic MACH4e at the recent VEITH Symposium in New York.
November 23, 2009 – The U.S. Food and Drug Administration (FDA) Nov. 20 approved Revatio (sildenafil) Injection, an intravenous formulation of Revatio, for the treatment of adult patients with pulmonary arterial hypertension (WHO Group I) to improve exercise ability and delay clinical worsening.
November 21, 2009 – Endovascular repair of a ruptured abdominal aortic aneurysm (EVAR) is superior to open repair, according to a study data released Nov. 18-22 at the VEITH Symposium in New York. The study found EVAR is best in patients with favorable anatomy and in centers that have access to vascular surgeons.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
November 18, 2009 — A new, reversible blood thinner did not prove superior over placebo for its primary endpoints of heart attack and need for revascularization, but it did reduce in-stent blood clots. Researchers reported the findings in a late-breaking clinical trial presentation at the American Heart Association’s Scientific Sessions this week.
November 20, 2009 – A new system that provides interactive road-mapping for interventional radiology, angiography, and vascular surgery, allows the physician to electronically draw or telestrate during live fluoro on the touch-screen monitor with a stylus. The telestration can then be used as a road-map to guide a catheter or perform an intervention during live, unsubtracted fluoro.
November 18, 2009 – Three platelet function tests identified patients who will have blood cells that remain sticky, increasing heart attack risk, despite being pretreated with two anti-clotting medications before coronary stenting. Researchers reported the findings at the American Heart Association’s Scientific Sessions this week.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 20, 2009 – A new service for endovascular specialists who treat aortic aneurysms converts 2D computed tomography (CT) axial images to 3D images of the anatomy and aneurysm measurement for device sizing, precase planning and patient follow-up.
November 18, 2009 – Patient enrollment was recently completed in the TRA 2 P-TIMI 50 clinical trial to study SCH 530348, an investigational anti-platelet protease activated receptor-1 (PAR-1) inhibitor.
November 18, 2009 – As part of a new partnership deal with QXMédical LLC, W. L. Gore & Associates will distribute the Q50 Stent Graft Balloon Catheter, which is designed for use with aortic stent grafts that treat abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA).